Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 1Recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1

Conditions

Uterine Cervical Neoplasms 18Endometrial Neoplasms 4Prostatic Neoplasms 3Sarcoma 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neuroectodermal Tumors, Primitive, Peripheral 2Esophageal Neoplasms 2Endometrial Clear Cell Adenocarcinoma 2Vaginal Neoplasms 1Uveitis 1Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Salivary Gland Neoplasms 1Radiation Injuries 1Obesity 1Neurotoxicity Syndromes 1Neoplasms, Unknown Primary 1Malignant mesenchymal tumor 1Lung Neoplasms 1Locally Advanced Cervical Cancer 1Locally Advanced Cervical Adenocarcinoma 1Liver Neoplasms 1Liposarcoma 1Hyperthermia 1Hemangiosarcoma 1Hemangiopericytoma, Malignant 1Head and Neck Neoplasms 1Fibrosarcoma 1Fatigue 1Esophageal Squamous Cell Carcinoma 1

Interventions

Radiotherapy 2Radiation 2Paclitaxel 2Cisplatin 2Carboplatin 2Brachytherapy 2Taxes 1Standard of Care 1Practice Guidelines as Topic 1Platinum 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Endometrial Clear Cell Adenocarcinoma × Brachytherapy × Clear all
NCT03422198 2025-12-12

SAVE

University of Utah

Phase 3 Recruiting
188 enrolled 15 charts
GynecologicSarcoma

Endometrial Clear Cell Adenocarcinoma

NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

GOG Foundation

Phase 3 Unknown
813 enrolled 14 charts
Gynecologic

Endometrial Clear Cell Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡